To test how reliable the tool recommend by Cochrane Collaboration for assessing risk of bias systematic reviews of randomized clinical trials is in the context of methylphenidate for children and adolescents with attention deficit hyperactivity disorder. Confirmatory factor analysis was 
| INTRODUCTION
Attention-deficit/hyperactivity disorder (ADHD) is characterized by pervasive and impairing levels of inattention and/or hyperactivity/ impulsivity (H/I; American Psychiatric Association, 2013), imposing an enormous burden on society (Maia et al., 2017) and affecting around 3.4% of children around the world (Polanczyk, Salum, Sugaya, Caye, & Rohde, 2015) . Methylphenidate is currently the most often prescribed drug to treat ADHD (Storebo et al., 2015) , and it has been used for over 50 years to treat children and adolescents. To congregate and evaluate the evidence around this issue, dozens of systematic reviews regarding methylphenidate's effectiveness for ADHD have been conducted, and judgment about the quality of the evidence has been made by using standardized instruments.
Various methodological shortcomings can introduce bias into
RCTs (Juni, Altman, & Egger, 2001) , which can threaten the quality of evidence. Critical appraisal of the design, conduct, and analysis of RCTs depends on their reported findings, which must also be assessed for their likelihood of accurately and completely reporting the trial methodology and outcomes. It is important that the reports provide clear information in order for readers to judge the reliability and validity of study results. This is especially important in systematic reviews, where different studies are combined to strengthen evidence of the effectiveness of a given intervention. In the context of systematic reviews and meta-analyses, different strategies have been employed to identify the presence of different sources of bias. The handbook for interventional systematic reviews developed by the Cochrane Collaboration (Higgins & Green, 2008) , in chapter 8, recommends the following indicators/items (called as "domains" by the authors) to assess risk of bias: random sequence generation, allocation concealment, blinding of participants and personnel, blinding of outcome assessment, incomplete outcome data, selective reporting, and other sources of bias where depending of the circumstance, any important concerns about bias not addressed in the other domains in the tool might be included.
Each indicator should be evaluated by the systematic review's authors on a Likert scale with three categories of answer: low, unclear,
| METHODS
The systematic review used to evaluate the risk of bias was "Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)" (Storebo et al., 2015) . It includes 38 parallel arm trials and 147 cross-over trials, totaling 185 primary RCTs. It represents a considerable range in terms of quality and nature of trials conducted since the 1980s. To evaluate the goodness of fit of the proposed unidimensional model, the following indices were used: chi-square (χ 2 ), confirmatory fit indices (CFI), the Tucker-Lewis index (TLI), and root mean square error approximation (RMSEA). The cutoff criteria used to determine the goodness of fit are described as following: chi-square with no statistical significance (>0.05), RMSEA near or less than 0.08, and CFI and TLI near or greater than 0.9 (Hu & Bentler, 1999) . We used the weighted least square using a diagonal weight matrix with standard errors and mean-and variance-adjusted estimator. All analyses were run in Mplus version 7.4, and the level of significance adopted was 0.05.
The precision of the set of items intending to measure risk of bias is not constant across the degree of bias. To identify in which part of the latent attribute the set of items gives more precision (i.e., amount of information), we used a total information curve. The utility of the total information curve is to inspect where, across the risk of bias attribute, the highest precision of measurement occurs. In the Y axis, we have the amount information. In the axis X, we have the range of the risk of bias latent attribute as a z-score and, therefore, ranging from −3 to 3 with a mean of zero where −3 is the highest risk of bias (lowest in terms of study quality) and +3 is the lowest risk of bias (highest in terms of study quality).
To evaluate Cochrane's risk of bias reliability, we adopted the Omega total (McDonald, 1970 (McDonald, , 2013 because the Cronbach's alpha requires unrealistic assumptions such as tau-equivalence and nonerror covariances (see McNeish, 2017; Raykov, 1997) . Omega, as a composite reliability index for congeneric scales, is closely related to Cronbach's alpha, assessing reliability via a ratio of the variability explained by items compared with the total variance of the entire scale (Bentler, 2007; Geldhof, Preacher, & Zyphur, 2014) .
| RESULTS
Initially, the unidimensional solution was tested. The goodness of fit indexes of the initial model were χ Therefore, the model has excellent fit indices and the factor loadings varied from 0.069 to 0.898, with i4, "blinding of outcome assessment," exhibiting the highest factor loading. The correlation of the residuals between i1 and i2, "random sequence generation" and "allocation concealment," was 0.489, indicating a moderate correlation. Table 1 showed the items' R 2 and their respective residual variances (measurement error). Figure 2 shows the total information curve for the seven items.
The peaks of information are in the negative part of the quality spectrum, which ranges from −3 to 0, indicating that the indicators provide more precise information in terms of risk of bias among studies with high risk of bias.
Lastly, the omega for the seven indicators is 0.642.
| DISCUSSION
In terms of goodness of fit (i.e., CFI, TLI, RMSEA), after a small alteration via modification indices, the measurement model constituted by seven indicators used in methylphenidate interventions in ADHD returned a model with excellent fit. It means, the model is very successful at reproducing the observed relationship in the input matrix (Brown, 2015, p. 135) . The "vested interest" bias added by Storebo et al. (2015) showed to be the lowest reliable indicator (λ = 0.069, p value = .497). Without it, we have an acceptable model: Because reliability is one component of validity (Carmines & Zeller, 1979; Nunnally, 1967) , it should be considered a critical aspect of CFA to establish construct validity, beyond goodness of fit. CFA includes the modeling of the measurement error associated with each indicator (latent variables regressed on the items with ε inside the ovals), and as observed, the majority of the items have a greater amount of measurement error than common variance. Measurement error is what establishes the reliability of each item (Kline, 2010) . In terms of reliability, only two indicators have very high factor loadings and low measurement error (49.5% and 80.7% of the variance is "accounted for" by the risk of bias latent factor for Items 3 and 4, respectively). Item 2 (allocation concealment) has a factor loading that could be considered adequate. Nunnally (1967, p. 369) asserts that it "is easy to overinterpret the meaning of small factor loadings, e.g., those below the factor that the corresponding indicator is intended to measure; it may be due to random measurement error or to item score unreliability (Kline, 2015, pp. 9-10) . Thus, it should be considered that the model in CFA, the goodness of fit does not apply because by its nature, it has a perfect fit; therefore, the goodness of fit a three-indicator unidimensional model was not tested here.
In terms of precision, the set of items are most reliable to measure RCT studies that are have greater risk of bias. As seen in Figure 2 , values higher than zero in the quality attribute have lower information.
The X-axis was ordered in terms of quality (not in amount of risk bias)
to better visualize the total information. Therefore, studies on the right of the graph are of better quality (i.e. lower in terms of risk of bias).
This asymmetry is expected due to the unipolar nature of the scale;
it is consistent with the way the items, and their responses were designed to detect studies with appreciable risk of bias (the items do not ask about positive attributes such as how strong the study is on a given criteria, only risk of weakness).
This study suggests new potential to evaluate risk of bias tools.
The approach might be applied to test risk of bias models in other systematic reviews, to determine whether the model holds in different contexts. Furthermore, it will be interesting to determine whether the reliability of the indicators is consistent in other contexts, because here we identify only two or three indicators that behave properly.
This may be specific to this area of study, or a general feature of the tool, bringing into question the reliability of its underlying measurement model. Although here we apply CFA to the Cochrane collaboration's method for evaluating risk of bias in systematic reviews of randomized clinical trials, the approach might also be applied in systematic reviews of other types, such as accuracy studies.
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